Medical device stocks include companies manufacturing surgical instruments, diagnostic equipment, implants, and therapeutic devices. Our AI evaluates FDA approval pipelines, recurring revenue, and R&D efficiency from SEC filings.
Top Medical Devices Stocks in 2026
Top-rated medical devices stocks ranked by AI confidence score. Dual AI analysis (Claude + ChatGPT) based on SEC 10-K and 10-Q filings. Last Updated: June 2026
DXCM
Confidence
86%
ISRG
Confidence
85%
IDXX
Confidence
82%
KRYS
Confidence
82%
RSMDF
Confidence
82%
NBIX
Confidence
81%
ELMD
Confidence
80%
AMGN
Confidence
79%
STE
Confidence
78%
GILD
Confidence
78%
PEN
Confidence
78%
IRMD
Confidence
78%
All Medical Devices Stocks (356)
| Ticker | Company | AI Rating | Confidence | Action |
|---|---|---|---|---|
| UEEC | United Health Products, Inc. | D | 98% | View Analysis → |
| SIGY | Sigyn Therapeutics, Inc. | D | 98% | View Analysis → |
| SINT | Sintx Technologies, Inc. | D | 96% | View Analysis → |
| AIM | AIM ImmunoTech Inc. | D | 96% | View Analysis → |
| ARMP | Armata Pharmaceuticals, Inc. | D | 96% | View Analysis → |
| RBOTW | Vicarious Surgical Inc. | D | 96% | View Analysis → |
| NIMU | NON INVASIVE MONITORING SYSTEMS INC /FL/ | D | 96% | View Analysis → |
| IRME | IR-Med, Inc. | D | 96% | View Analysis → |
| ENDV | ENDONOVO THERAPEUTICS, INC. | D | 96% | View Analysis → |
| RVP | RETRACTABLE TECHNOLOGIES INC | D | 95% | View Analysis → |
| VNRX | VOLITIONRX LTD | D | 95% | View Analysis → |
| PAVM | PAVmed Inc. | D | 95% | View Analysis → |
| AVR | Anteris Technologies Global Corp. | D | 95% | View Analysis → |
| ZIVOW | Zivo Bioscience, Inc. | D | 95% | View Analysis → |
| YBGJ | Yubo International Biotech Ltd | D | 95% | View Analysis → |
| XAIR | Beyond Air, Inc. | D | 95% | View Analysis → |
| VERO | Venus Concept Inc. | D | 95% | View Analysis → |
| TVGNW | Tevogen Bio Holdings Inc. | D | 95% | View Analysis → |
| STSSW | Sharps Technology Inc. | D | 95% | View Analysis → |
| STME | Stimcell Energetics Inc. | D | 95% | View Analysis → |
| SNOA | Sonoma Pharmaceuticals, Inc. | D | 95% | View Analysis → |
| SGP | SpyGlass Pharma, Inc. | D | 95% | View Analysis → |
| SCLXW | Scilex Holding Co | D | 95% | View Analysis → |
| RTGN | RetinalGenix Technologies Inc. | D | 95% | View Analysis → |
| PREM | Premier Air Charter Holdings Inc. | D | 95% | View Analysis → |
| POSC | POSITRON CORP | D | 95% | View Analysis → |
| PMI | Picard Medical, Inc. | D | 95% | View Analysis → |
| ADGM | Adagio Medical Holdings, Inc. | D | 94% | View Analysis → |
| CODX | Co-Diagnostics, Inc. | D | 94% | View Analysis → |
| GCTK | Glucotrack, Inc. | D | 94% | View Analysis → |
| MCAGU | Mountain Crest Acquisition Corp. V | D | 94% | View Analysis → |
| LYRA | Lyra Therapeutics, Inc. | D | 94% | View Analysis → |
| EMED | Electromedical Technologies, Inc | D | 94% | View Analysis → |
| EBRCZ | EBR Systems, Inc. | D | 94% | View Analysis → |
| BCDA | BioCardia, Inc. | D | 93% | View Analysis → |
| BCAB | BioAtla, Inc. | D | 93% | View Analysis → |
| FTII | FutureTech II Acquisition Corp. | D | 93% | View Analysis → |
| FOFA | FAMILY OFFICE OF AMERICA, INC. | D | 93% | View Analysis → |
| ESLAW | Estrella Immunopharma, Inc. | D | 93% | View Analysis → |
| ENZN | ENZON PHARMACEUTICALS, INC. | D | 93% | View Analysis → |
| IVF | INVO Fertility, Inc. | D | 92% | View Analysis → |
| PSTV | PLUS THERAPEUTICS, INC. | D | 92% | View Analysis → |
| VVOS | Vivos Therapeutics, Inc. | D | 92% | View Analysis → |
| ATRA | Atara Biotherapeutics, Inc. | D | 92% | View Analysis → |
| STEX | Streamex Corp. | D | 92% | View Analysis → |
| TARA | Protara Therapeutics, Inc. | D | 92% | View Analysis → |
| CVM | CEL SCI CORP | D | 92% | View Analysis → |
| PLUR | Pluri Inc. | D | 92% | View Analysis → |
| VANI | Vivani Medical, Inc. | D | 92% | View Analysis → |
| CELZ | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | D | 92% | View Analysis → |
| ZEOX | Zeo ScientifiX, Inc. | D | 92% | View Analysis → |
| VACHW | Voyager Acquisition Corp./Cayman Islands | D | 92% | View Analysis → |
| ODYY | Odyssey Health, Inc. | D | 92% | View Analysis → |
| GTHP | GUIDED THERAPEUTICS INC | D | 92% | View Analysis → |
| GPLB | Green Planet Bio Engineering Co. Ltd. | D | 92% | View Analysis → |
| NVACW | Profusa, Inc. | D | 92% | View Analysis → |
| NUMD | Nu-Med Plus, Inc. | D | 92% | View Analysis → |
| MDAIW | Spectral AI, Inc. | D | 92% | View Analysis → |
| AMIX | Autonomix Medical, Inc. | D | 90% | View Analysis → |
| OTLK | Outlook Therapeutics, Inc. | D | 90% | View Analysis → |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | C | 90% | View Analysis → |
| CRIS | CURIS INC | C | 90% | View Analysis → |
| XFOR | X4 Pharmaceuticals, Inc | D | 90% | View Analysis → |
| PCVX | Vaxcyte, Inc. | D | 90% | View Analysis → |
| TIVC | Tivic Health Systems, Inc. | D | 90% | View Analysis → |
| SSKN | STRATA Skin Sciences, Inc. | D | 90% | View Analysis → |
| LIMNW | Liminatus Pharma, Inc. | D | 90% | View Analysis → |
| FNCH | Finch Therapeutics Group, Inc. | D | 90% | View Analysis → |
| CYH | COMMUNITY HEALTH SYSTEMS INC | C | 89% | View Analysis → |
| QCLS | Q/C TECHNOLOGIES, INC. | D | 88% | View Analysis → |
| PHGE | BiomX Inc. | D | 88% | View Analysis → |
| FEED | ENvue Medical, Inc. | D | 88% | View Analysis → |
| INKT | MiNK Therapeutics, Inc. | D | 88% | View Analysis → |
| CRDF | Cardiff Oncology, Inc. | D | 88% | View Analysis → |
| TIL | Instil Bio, Inc. | D | 88% | View Analysis → |
| ATYR | aTYR PHARMA INC | D | 88% | View Analysis → |
| SSII | SS Innovations International, Inc. | C | 88% | View Analysis → |
| MBOT | Microbot Medical Inc. | C | 88% | View Analysis → |
| LUCD | Lucid Diagnostics Inc. | D | 88% | View Analysis → |
| DRIO | DarioHealth Corp. | D | 88% | View Analysis → |
| PTHS | Pelthos Therapeutics Inc. | D | 88% | View Analysis → |
| MGTX | MeiraGTx Holdings plc | D | 88% | View Analysis → |
| SGMO | SANGAMO THERAPEUTICS, INC | D | 88% | View Analysis → |
| EXOZ | EXOZYMES INC. | D | 88% | View Analysis → |
| BJDX | Bluejay Diagnostics, Inc. | D | 88% | View Analysis → |
| IMDX | Insight Molecular Diagnostics Inc. | D | 88% | View Analysis → |
| SRTS | Sensus Healthcare, Inc. | D | 88% | View Analysis → |
| AGEN | AGENUS INC | D | 88% | View Analysis → |
| TMCI | TREACE MEDICAL CONCEPTS, INC. | C | 88% | View Analysis → |
| ENOV | Enovis CORP | C | 88% | View Analysis → |
| SLXNW | Silexion Therapeutics Corp | D | 88% | View Analysis → |
| RVMDW | Revolution Medicines, Inc. | D | 88% | View Analysis → |
| QTIWW | QT IMAGING HOLDINGS, INC. | D | 88% | View Analysis → |
| PETVW | PetVivo Holdings, Inc. | D | 88% | View Analysis → |
| OSRHW | OSR Holdings, Inc. | D | 88% | View Analysis → |
| HSCSW | HeartSciences Inc. | D | 88% | View Analysis → |
| RDGL | VIVOS INC | D | 88% | View Analysis → |
| MODD | Modular Medical, Inc. | D | 88% | View Analysis → |
| SLDB | Solid Biosciences Inc. | C | 87% | View Analysis → |
| CLDX | Celldex Therapeutics, Inc. | D | 87% | View Analysis → |
| NUWE | Nuwellis, Inc. | D | 87% | View Analysis → |
| POCI | PRECISION OPTICS CORPORATION, INC. | D | 87% | View Analysis → |
| DYAI | DYADIC INTERNATIONAL INC | C | 87% | View Analysis → |
| TELA | TELA Bio, Inc. | D | 87% | View Analysis → |
| CLPT | ClearPoint Neuro, Inc. | C | 87% | View Analysis → |
| SRZNW | Surrozen, Inc./DE | D | 87% | View Analysis → |
| CRBU | Caribou Biosciences, Inc. | C | 86% | View Analysis → |
| RGNX | REGENXBIO Inc. | D | 86% | View Analysis → |
| IBRX | ImmunityBio, Inc. | D | 86% | View Analysis → |
| ECOR | electroCore, Inc. | C | 86% | View Analysis → |
| ARAY | ACCURAY INC | C | 86% | View Analysis → |
| DXCM | DEXCOM INC | A | 86% | View Analysis → |
| GRST | ETHEMA HEALTH Corp | D | 86% | View Analysis → |
| MHUAF | Meihua International Medical Technologies Co., Ltd. | C | 86% | View Analysis → |
| ESMC | ESCALON MEDICAL CORP | C | 86% | View Analysis → |
| DYNTQ | DYNATRONICS CORP | C | 86% | View Analysis → |
| VTAK | Catheter Precision, Inc. | D | 85% | View Analysis → |
| STRO | SUTRO BIOPHARMA, INC. | D | 85% | View Analysis → |
| VOR | Vor Biopharma Inc. | D | 85% | View Analysis → |
| MLSS | MILESTONE SCIENTIFIC INC. | D | 85% | View Analysis → |
| SNTI | Senti Biosciences, Inc. | D | 85% | View Analysis → |
| SKIN | Beauty Health Co | C | 85% | View Analysis → |
| VYGR | Voyager Therapeutics, Inc. | D | 85% | View Analysis → |
| ISRG | INTUITIVE SURGICAL INC | A | 85% | View Analysis → |
| VYCO | VYCOR MEDICAL INC | D | 85% | View Analysis → |
| VIVS | VivoSim Labs, INC. | D | 85% | View Analysis → |
| TNONW | Tenon Medical, Inc. | D | 85% | View Analysis → |
| TLSIW | TriSalus Life Sciences, Inc. | D | 85% | View Analysis → |
| NXGLW | NEXGEL, INC. | C | 85% | View Analysis → |
| ALEC | Alector, Inc. | C | 84% | View Analysis → |
| NXL | Nexalin Technology, Inc. | D | 84% | View Analysis → |
| INBS | INTELLIGENT BIO SOLUTIONS INC. | D | 84% | View Analysis → |
| GUTS | FRACTYL HEALTH, INC. | C | 84% | View Analysis → |
| OCGN | Ocugen, Inc. | D | 84% | View Analysis → |
| BAX | BAXTER INTERNATIONAL INC | C | 84% | View Analysis → |
| HRGN | Harvard Apparatus Regenerative Technology, Inc. | D | 84% | View Analysis → |
| NTRBW | NutriBand Inc. | C | 84% | View Analysis → |
| IPHYF | Innate Pharma SA | C | 84% | View Analysis → |
| ENGNW | enGene Holdings Inc. | C | 84% | View Analysis → |
| ECIA | ENCISION INC | C | 84% | View Analysis → |
| ELUT | ELUTIA INC. | C | 83% | View Analysis → |
| CV | CapsoVision, Inc | D | 83% | View Analysis → |
| MGX | Metagenomi Therapeutics, Inc. | C | 83% | View Analysis → |
| LXEO | Lexeo Therapeutics, Inc. | C | 83% | View Analysis → |
| HUMAW | Humacyte, Inc. | D | 83% | View Analysis → |
| EVAX | Evaxion A/S | C | 83% | View Analysis → |
| FDMT | 4D Molecular Therapeutics, Inc. | C | 82% | View Analysis → |
| CMPX | Compass Therapeutics, Inc. | C | 82% | View Analysis → |
| CGEM | Cullinan Therapeutics, Inc. | C | 82% | View Analysis → |
| ARTV | Artiva Biotherapeutics, Inc. | C | 82% | View Analysis → |
| CTSO | Cytosorbents Corp | C | 82% | View Analysis → |
| SMTI | Sanara MedTech Inc. | D | 82% | View Analysis → |
| ALLO | Allogene Therapeutics, Inc. | D | 82% | View Analysis → |
| ENTX | Entera Bio Ltd. | C | 82% | View Analysis → |
| APYX | Apyx Medical Corp | C | 82% | View Analysis → |
| ESTA | ESTABLISHMENT LABS HOLDINGS INC. | C | 82% | View Analysis → |
| NSPR | InspireMD, Inc. | D | 82% | View Analysis → |
| QDEL | QuidelOrtho Corp | C | 82% | View Analysis → |
| IDXX | IDEXX LABORATORIES INC /DE | A+ | 82% | View Analysis → |
| DTIL | PRECISION BIOSCIENCES INC | C | 82% | View Analysis → |
| KRYS | Krystal Biotech, Inc. | A | 82% | View Analysis → |
| RSMDF | RESMED INC | A+ | 82% | View Analysis → |
| JSPRW | Jasper Therapeutics, Inc. | D | 82% | View Analysis → |
| FATE | FATE THERAPEUTICS INC | C | 81% | View Analysis → |
| ALGS | Aligos Therapeutics, Inc. | C | 81% | View Analysis → |
| NBIX | NEUROCRINE BIOSCIENCES INC | A | 81% | View Analysis → |
| LFWD | Lifeward Ltd. | C | 80% | View Analysis → |
| FEMY | FEMASYS INC | C | 80% | View Analysis → |
| ELMD | Electromed, Inc. | A | 80% | View Analysis → |
| ABOS | Acumen Pharmaceuticals, Inc. | C | 80% | View Analysis → |
| TFX | TELEFLEX INC | C | 80% | View Analysis → |
| NVAX | NOVAVAX INC | C | 80% | View Analysis → |
| BCRX | BIOCRYST PHARMACEUTICALS INC | B | 80% | View Analysis → |
| ATEC | Alphatec Holdings, Inc. | C | 80% | View Analysis → |
| LUNG | Pulmonx Corp | C | 80% | View Analysis → |
| NDRA | ENDRA Life Sciences Inc. | D | 79% | View Analysis → |
| IRIX | IRIDEX CORP | C | 79% | View Analysis → |
| INBX | Inhibrx Biosciences, Inc. | C | 79% | View Analysis → |
| BDX | BECTON DICKINSON & CO | C | 79% | View Analysis → |
| AMGN | AMGEN INC | A | 79% | View Analysis → |
| STE | STERIS plc | A | 78% | View Analysis → |
| SPAI | Safe Pro Group Inc. | D | 78% | View Analysis → |
| FONR | FONAR CORP | B | 78% | View Analysis → |
| TECX | Tectonic Therapeutic, Inc. | C | 78% | View Analysis → |
| STXS | Stereotaxis, Inc. | C | 78% | View Analysis → |
| EDIT | Editas Medicine, Inc. | C | 78% | View Analysis → |
| CVRX | CVRx, Inc. | C | 78% | View Analysis → |
| LONA | LeonaBio, Inc. | C | 78% | View Analysis → |
| GILD | GILEAD SCIENCES, INC. | A | 78% | View Analysis → |
| TKNO | Alpha Teknova, Inc. | C | 78% | View Analysis → |
| SGHT | Sight Sciences, Inc. | C | 78% | View Analysis → |
| STIM | Neuronetics, Inc. | C | 78% | View Analysis → |
| SGRY | Surgery Partners, Inc. | C | 78% | View Analysis → |
| MYGN | MYRIAD GENETICS INC | C | 78% | View Analysis → |
| PEN | Penumbra Inc | A | 78% | View Analysis → |
| IRMD | IRADIMED CORP | A | 78% | View Analysis → |
| CERS | CERUS CORP | C | 78% | View Analysis → |
| MDXG | MIMEDX GROUP, INC. | C | 78% | View Analysis → |
| SABSW | SAB Biotherapeutics, Inc. | D | 78% | View Analysis → |
| PMCB | PharmaCyte Biotech, Inc. | C | 78% | View Analysis → |
| NEOG | NEOGEN CORP | C | 78% | View Analysis → |
| GIPL | Global Innovative Platforms Inc. | C | 78% | View Analysis → |
| MNESP | MSA Safety Inc | A | 78% | View Analysis → |
| CABA | Cabaletta Bio, Inc. | C | 77% | View Analysis → |
| ACOG | Alpha Cognition Inc. | C | 77% | View Analysis → |
| CCCC | C4 Therapeutics, Inc. | C | 77% | View Analysis → |
| SYK | STRYKER CORP | A | 77% | View Analysis → |
| LNSR | LENSAR, Inc. | C | 77% | View Analysis → |
| LMAT | LEMAITRE VASCULAR INC | A | 77% | View Analysis → |
| INSP | Inspire Medical Systems, Inc. | A | 77% | View Analysis → |
| BSX | BOSTON SCIENTIFIC CORP | A | 77% | View Analysis → |
| APT | ALPHA PRO TECH LTD | C | 76% | View Analysis → |
| CGON | CG Oncology, Inc. | C | 76% | View Analysis → |
| TNDM | TANDEM DIABETES CARE INC | C | 76% | View Analysis → |
| OSUR | ORASURE TECHNOLOGIES INC | C | 76% | View Analysis → |
| INGN | Inogen Inc | C | 76% | View Analysis → |
| CGTX | COGNITION THERAPEUTICS INC | C | 76% | View Analysis → |
| AORT | ARTIVION, INC. | C | 76% | View Analysis → |
| ADMA | ADMA BIOLOGICS, INC. | A | 76% | View Analysis → |
| MASI | MASIMO CORP | A | 76% | View Analysis → |
| EW | Edwards Lifesciences Corp | C | 76% | View Analysis → |
| IART | INTEGRA LIFESCIENCES HOLDINGS CORP | C | 76% | View Analysis → |
| MRNA | Moderna, Inc. | C | 76% | View Analysis → |
| KIDS | ORTHOPEDIATRICS CORP | C | 76% | View Analysis → |
| ITGR | Integer Holdings Corp | C | 76% | View Analysis → |
| ANIK | Anika Therapeutics, Inc. | C | 76% | View Analysis → |
| HCA | HCA Healthcare, Inc. | A | 76% | View Analysis → |
| LGMK | LogicMark, Inc. | C | 76% | View Analysis → |
| SANA | Sana Biotechnology, Inc. | C | 75% | View Analysis → |
| CADL | Candel Therapeutics, Inc. | C | 75% | View Analysis → |
| NRXS | Neuraxis, INC | C | 75% | View Analysis → |
| CHRS | Coherus Oncology, Inc. | C | 75% | View Analysis → |
| UTMD | UTAH MEDICAL PRODUCTS INC | B | 75% | View Analysis → |
| PDEX | PRO DEX INC | A | 75% | View Analysis → |
| IOVA | IOVANCE BIOTHERAPEUTICS, INC. | C | 75% | View Analysis → |
| TECH | BIO-TECHNE Corp | B | 75% | View Analysis → |
| SOLV | Solventum Corp | C | 75% | View Analysis → |
| EXEL | EXELIXIS, INC. | A | 75% | View Analysis → |
| EMBC | Embecta Corp. | B | 75% | View Analysis → |
| MMSI | MERIT MEDICAL SYSTEMS INC | A | 75% | View Analysis → |
| IRTC | iRhythm Holdings, Inc. | C | 75% | View Analysis → |
| AXGN | Axogen, Inc. | C | 75% | View Analysis → |
| MMM | 3M CO | B | 75% | View Analysis → |
| AURA | Aura Biosciences, Inc. | C | 74% | View Analysis → |
| AUTL | Autolus Therapeutics plc | C | 74% | View Analysis → |
| KOD | Kodiak Sciences Inc. | C | 74% | View Analysis → |
| KYTX | Kyverna Therapeutics, Inc. | C | 74% | View Analysis → |
| OBIO | Orchestra BioMed Holdings, Inc. | C | 74% | View Analysis → |
| BDTX | Black Diamond Therapeutics, Inc. | C | 74% | View Analysis → |
| CDRE | Cadre Holdings, Inc. | B | 74% | View Analysis → |
| INMB | Inmune Bio, Inc. | C | 74% | View Analysis → |
| GMED | GLOBUS MEDICAL INC | A | 74% | View Analysis → |
| DNLI | Denali Therapeutics Inc. | C | 74% | View Analysis → |
| UHS | UNIVERSAL HEALTH SERVICES INC | A | 74% | View Analysis → |
| AVNS | AVANOS MEDICAL, INC. | C | 74% | View Analysis → |
| ARDT | Ardent Health, Inc. | C | 74% | View Analysis → |
| ADPT | Adaptive Biotechnologies Corp | B | 74% | View Analysis → |
| WST | WEST PHARMACEUTICAL SERVICES INC | A | 74% | View Analysis → |
| REPL | Replimune Group, Inc. | D | 74% | View Analysis → |
| ICCC | IMMUCELL CORP /DE/ | A | 73% | View Analysis → |
| MYO | MYOMO, INC. | C | 73% | View Analysis → |
| BEAM | Beam Therapeutics Inc. | B | 73% | View Analysis → |
| ALGN | ALIGN TECHNOLOGY INC | A | 73% | View Analysis → |
| KYMR | Kymera Therapeutics, Inc. | C | 73% | View Analysis → |
| LAKE | LAKELAND INDUSTRIES INC | C | 72% | View Analysis → |
| PRME | Prime Medicine, Inc. | C | 72% | View Analysis → |
| PLSE | PULSE BIOSCIENCES, INC. | C | 72% | View Analysis → |
| IMA | ImageneBio, Inc. | C | 72% | View Analysis → |
| PROK | PROKIDNEY CORP. | C | 72% | View Analysis → |
| FENC | FENNEC PHARMACEUTICALS INC. | C | 72% | View Analysis → |
| QNCX | Quince Therapeutics, Inc. | C | 72% | View Analysis → |
| NMTC | NEUROONE MEDICAL TECHNOLOGIES Corp | C | 72% | View Analysis → |
| NMRA | Neumora Therapeutics, Inc. | C | 72% | View Analysis → |
| SNWV | SANUWAVE Health, Inc. | C | 72% | View Analysis → |
| LENZ | LENZ Therapeutics, Inc. | C | 72% | View Analysis → |
| INFU | InfuSystem Holdings, Inc | A | 72% | View Analysis → |
| DCTH | DELCATH SYSTEMS, INC. | A | 72% | View Analysis → |
| TNYA | Tenaya Therapeutics, Inc. | C | 72% | View Analysis → |
| LNTH | Lantheus Holdings, Inc. | A | 72% | View Analysis → |
| CRSP | CRISPR Therapeutics AG | C | 72% | View Analysis → |
| NVNO | enVVeno Medical Corp | C | 72% | View Analysis → |
| TWST | Twist Bioscience Corp | B | 72% | View Analysis → |
| RXRX | RECURSION PHARMACEUTICALS, INC. | C | 72% | View Analysis → |
| RLAY | Relay Therapeutics, Inc. | C | 72% | View Analysis → |
| BIIB | BIOGEN INC. | B | 72% | View Analysis → |
| BBNX | Beta Bionics, Inc. | C | 72% | View Analysis → |
| VASO | VASO Corp | B | 72% | View Analysis → |
| USAQ | QHSLab, Inc. | C | 72% | View Analysis → |
| MDNC | Medinotec Inc. | A | 72% | View Analysis → |
| HAE | HAEMONETICS CORP | B | 71% | View Analysis → |
| NTLA | Intellia Therapeutics, Inc. | C | 71% | View Analysis → |
| IVVD | Invivyd, Inc. | C | 71% | View Analysis → |
| HYPR | Hyperfine, Inc. | C | 71% | View Analysis → |
| CBLL | Ceribell, Inc. | B | 71% | View Analysis → |
| APGE | Apogee Therapeutics, Inc. | C | 71% | View Analysis → |
| OFIX | Orthofix Medical Inc. | C | 71% | View Analysis → |
| ATRC | AtriCure, Inc. | B | 71% | View Analysis → |
| IMVT | Immunovant, Inc. | C | 70% | View Analysis → |
| GLUE | Monte Rosa Therapeutics, Inc. | C | 70% | View Analysis → |
| MAZE | Maze Therapeutics, Inc. | B | 70% | View Analysis → |
| PASG | Passage BIO, Inc. | C | 70% | View Analysis → |
| VCEL | Vericel Corp | B | 70% | View Analysis → |
| TARS | Tarsus Pharmaceuticals, Inc. | A | 70% | View Analysis → |
| PODD | INSULET CORP | B | 70% | View Analysis → |
| RGEN | REPLIGEN CORP | A | 70% | View Analysis → |
| CARL | CARLSMED, INC. | B | 70% | View Analysis → |
| BVS | Bioventus Inc. | C | 70% | View Analysis → |
| GKOS | GLAUKOS Corp | B | 70% | View Analysis → |
| KLRS | Kalaris Therapeutics, Inc. | C | 69% | View Analysis → |
| LIVN | LivaNova PLC | B | 69% | View Analysis → |
| INTS | INTENSITY THERAPEUTICS, INC. | C | 68% | View Analysis → |
| XTNT | Xtant Medical Holdings, Inc. | C | 68% | View Analysis → |
| SRRK | Scholar Rock Holding Corp | C | 68% | View Analysis → |
| BLFS | BIOLIFE SOLUTIONS INC | B | 68% | View Analysis → |
| TMDX | TransMedics Group, Inc. | B | 68% | View Analysis → |
| THC | TENET HEALTHCARE CORP | B | 68% | View Analysis → |
| ZBH | ZIMMER BIOMET HOLDINGS, INC. | B | 68% | View Analysis → |
| IKT | Inhibikase Therapeutics, Inc. | C | 67% | View Analysis → |
| HTFL | Heartflow, Inc. | B | 66% | View Analysis → |
| NPCE | NeuroPace Inc | C | 66% | View Analysis → |
| LCTX | Lineage Cell Therapeutics, Inc. | C | 66% | View Analysis → |
| NEPH | NEPHROS INC | A | 66% | View Analysis → |
| ICUI | ICU MEDICAL INC/DE | B | 66% | View Analysis → |
| KRMD | KORU Medical Systems, Inc. | A | 66% | View Analysis → |
| INAB | IN8BIO, INC. | C | 66% | View Analysis → |
| IMCR | Immunocore Holdings plc | A | 66% | View Analysis → |
| ZURA | Zura Bio Ltd | B | 65% | View Analysis → |
| SI | SHOULDER INNOVATIONS, INC. | B | 65% | View Analysis → |
| PROF | Profound Medical Corp. | B | 65% | View Analysis → |
| VIR | Vir Biotechnology, Inc. | C | 65% | View Analysis → |
| TSHA | Taysha Gene Therapies, Inc. | B | 65% | View Analysis → |
| IDXG | INTERPACE BIOSCIENCES, INC. | B | 65% | View Analysis → |
| ICUCW | SeaStar Medical Holding Corp | C | 65% | View Analysis → |
| HALO | HALOZYME THERAPEUTICS, INC. | B | 64% | View Analysis → |
| KMTS | KESTRA MEDICAL TECHNOLOGIES, LTD. | B | 64% | View Analysis → |
| HCIL | Hongchang International Co., Ltd | C | 64% | View Analysis → |
| PRCT | PROCEPT BioRobotics Corp | B | 63% | View Analysis → |
| UFPT | UFP TECHNOLOGIES INC | B | 62% | View Analysis → |
| NVCR | NovoCure Ltd | B | 61% | View Analysis → |
| NNNN | Anbio Biotechnology | C | 60% | View Analysis → |
| IPSC | Century Therapeutics, Inc. | C | 58% | View Analysis → |
| OM | Outset Medical, Inc. | C | 58% | View Analysis → |
| TCMD | TACTILE SYSTEMS TECHNOLOGY INC | B | 58% | View Analysis → |
| PALI | PALISADE BIO, INC. | B | 55% | View Analysis → |
| SIBN | SI-BONE, Inc. | B | 55% | View Analysis → |
| MDLN | Medline Inc. | C | 55% | View Analysis → |
| PLX | Protalix BioTherapeutics, Inc. | B | 52% | View Analysis → |
| TCRX | TScan Therapeutics, Inc. | C | 50% | View Analysis → |
| VXRT | Vaxart, Inc. | B | 48% | View Analysis → |
| INMD | InMode Ltd. | B | 42% | View Analysis → |
| EIKN | Eikon Therapeutics, Inc. | B | 41% | View Analysis → |
| EDAP | EDAP TMS SA | B | 39% | View Analysis → |
| MOLN | MOLECULAR PARTNERS AG | B | 18% | View Analysis → |
| MMED | MiniMed Group, Inc. | C | 18% | View Analysis → |
| RGNT | REGENTIS BIOMATERIALS LTD. | B | 16% | View Analysis → |
| MEOBF | MESOBLAST LTD | B | 5% | View Analysis → |
Frequently Asked Questions: Medical Devices Stocks
What are the best medical devices stocks to buy in 2026?
Based on our dual AI fundamental analysis (Claude and ChatGPT), 37 medical devices stocks have A+ or A grades in 2026. These are ranked by confidence score based on SEC 10-K and 10-Q filing analysis.
Which medical devices stocks have A+ grades?
Currently, 2 medical devices stocks have an A+ grade from our AI analysis. A+ indicates both Claude and ChatGPT agree on exceptional fundamentals with high confidence scores above 80%.
How does AI analyze medical devices stocks?
Our dual AI system analyzes SEC EDGAR filings including revenue growth, profit margins, ROE, ROA, debt levels, and cash flow. Both Claude (Anthropic) and ChatGPT (OpenAI) independently evaluate each stock, then we combine their ratings for higher accuracy.
What is the AI confidence score?
AI confidence scores range from 0-100% and indicate how strongly the AI models agree on their rating. Higher confidence means clearer signals from SEC filing data. Medical devices stocks with 80%+ confidence have the most reliable ratings.
Should I invest in medical devices stocks in 2026?
Our AI analysis shows 37 Buy ratings vs 271 Sell ratings in the medical devices sector. Individual stock fundamentals vary significantly - review each stock's detailed analysis. This is not investment advice.
How often are medical devices stock ratings updated?
AI ratings are updated whenever companies file new SEC reports (10-K annually, 10-Q quarterly). Most medical devices stocks are re-analyzed within 24-48 hours of new filings being published on SEC EDGAR.
What data sources are used for medical devices stock analysis?
All analysis is based on official SEC EDGAR filings including Form 10-K (annual reports), Form 10-Q (quarterly reports), and other regulatory disclosures. We do not use price data or market sentiment - only fundamental financial data.
Compare Top Medical Devices Stocks
Part of: 💊 Healthcare Sector